Summary

According to our LPI (LP Information) latest study, the global Rabies Immune Globulin market size was valued at US$ million in 2022. With growing demand in downstream market, the Rabies Immune Globulin is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Rabies Immune Globulin market. Rabies Immune Globulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Rabies Immune Globulin. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Rabies Immune Globulin market.
Key Features:
The report on Rabies Immune Globulin market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Rabies Immune Globulin market. It may include historical data, market segmentation by Type (e.g., HRIG, ERIG), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Rabies Immune Globulin market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Rabies Immune Globulin market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Rabies Immune Globulin industry. This include advancements in Rabies Immune Globulin technology, Rabies Immune Globulin new entrants, Rabies Immune Globulin new investment, and other innovations that are shaping the future of Rabies Immune Globulin.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Rabies Immune Globulin market. It includes factors influencing customer ' purchasing decisions, preferences for Rabies Immune Globulin product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Rabies Immune Globulin market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Rabies Immune Globulin market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Rabies Immune Globulin market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Rabies Immune Globulin industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Rabies Immune Globulin market.
Market Segmentation:
Rabies Immune Globulin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
HRIG
ERIG
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Sanofi Pasteur
Novartis
Beringer Ingelheim
Kedrion Biopharma
Shenzhen Kangtai Biological Products Co., Ltd.
Chongqing Zhifei Biological Products Co., Ltd.
Liaoning Chengda Biotechnology Co., Ltd.
Hualan Biological Engineering,Inc.
China Resources Boya Bio-pharmaceutical Group Co., Ltd.
Shanxi Kangbao Biological Product Co., Ltd.
Wuhan Biopharmaceutical Co., Ltd. of China National Pharmaceutical Group
Guangdong Wellen Pharmaceutical Co., Ltd.
Shenzhen Weiguang Biological Products Co., Ltd.
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Guangdong Shuanglin Bio-Pharmacy Co., Ltd.
Wuhan Zhong Yuan Rui De Biological Products Co., Ltd.
Shandong Taibang Biological Products Co., Ltd.
Bohui Biopharmaceutical (Hebei) Co., Ltd.
Tonrol Bio-Pharmaceutical Co.,Limited
Hunan Ziguang Huhan Nanyue Pharmaceutical Co., Ltd.
Chengdu Rongsheng Pharmaceuticals Co., Ltd.
Harbin Pacific Biopharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rabies Immune Globulin market?
What factors are driving Rabies Immune Globulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rabies Immune Globulin market opportunities vary by end market size?
How does Rabies Immune Globulin break out type, application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rabies Immune Globulin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rabies Immune Globulin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rabies Immune Globulin by Country/Region, 2018, 2022 & 2029
2.2 Rabies Immune Globulin Segment by Type
2.2.1 HRIG
2.2.2 ERIG
2.3 Rabies Immune Globulin Sales by Type
2.3.1 Global Rabies Immune Globulin Sales Market Share by Type (2018-2023)
2.3.2 Global Rabies Immune Globulin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rabies Immune Globulin Sale Price by Type (2018-2023)
2.4 Rabies Immune Globulin Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Rabies Immune Globulin Sales by Application
2.5.1 Global Rabies Immune Globulin Sale Market Share by Application (2018-2023)
2.5.2 Global Rabies Immune Globulin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rabies Immune Globulin Sale Price by Application (2018-2023)
3 Global Rabies Immune Globulin by Company
3.1 Global Rabies Immune Globulin Breakdown Data by Company
3.1.1 Global Rabies Immune Globulin Annual Sales by Company (2018-2023)
3.1.2 Global Rabies Immune Globulin Sales Market Share by Company (2018-2023)
3.2 Global Rabies Immune Globulin Annual Revenue by Company (2018-2023)
3.2.1 Global Rabies Immune Globulin Revenue by Company (2018-2023)
3.2.2 Global Rabies Immune Globulin Revenue Market Share by Company (2018-2023)
3.3 Global Rabies Immune Globulin Sale Price by Company
3.4 Key Manufacturers Rabies Immune Globulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rabies Immune Globulin Product Location Distribution
3.4.2 Players Rabies Immune Globulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rabies Immune Globulin by Geographic Region
4.1 World Historic Rabies Immune Globulin Market Size by Geographic Region (2018-2023)
4.1.1 Global Rabies Immune Globulin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rabies Immune Globulin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rabies Immune Globulin Market Size by Country/Region (2018-2023)
4.2.1 Global Rabies Immune Globulin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rabies Immune Globulin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rabies Immune Globulin Sales Growth
4.4 APAC Rabies Immune Globulin Sales Growth
4.5 Europe Rabies Immune Globulin Sales Growth
4.6 Middle East & Africa Rabies Immune Globulin Sales Growth
5 Americas
5.1 Americas Rabies Immune Globulin Sales by Country
5.1.1 Americas Rabies Immune Globulin Sales by Country (2018-2023)
5.1.2 Americas Rabies Immune Globulin Revenue by Country (2018-2023)
5.2 Americas Rabies Immune Globulin Sales by Type
5.3 Americas Rabies Immune Globulin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rabies Immune Globulin Sales by Region
6.1.1 APAC Rabies Immune Globulin Sales by Region (2018-2023)
6.1.2 APAC Rabies Immune Globulin Revenue by Region (2018-2023)
6.2 APAC Rabies Immune Globulin Sales by Type
6.3 APAC Rabies Immune Globulin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rabies Immune Globulin by Country
7.1.1 Europe Rabies Immune Globulin Sales by Country (2018-2023)
7.1.2 Europe Rabies Immune Globulin Revenue by Country (2018-2023)
7.2 Europe Rabies Immune Globulin Sales by Type
7.3 Europe Rabies Immune Globulin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rabies Immune Globulin by Country
8.1.1 Middle East & Africa Rabies Immune Globulin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rabies Immune Globulin Revenue by Country (2018-2023)
8.2 Middle East & Africa Rabies Immune Globulin Sales by Type
8.3 Middle East & Africa Rabies Immune Globulin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rabies Immune Globulin
10.3 Manufacturing Process Analysis of Rabies Immune Globulin
10.4 Industry Chain Structure of Rabies Immune Globulin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rabies Immune Globulin Distributors
11.3 Rabies Immune Globulin Customer
12 World Forecast Review for Rabies Immune Globulin by Geographic Region
12.1 Global Rabies Immune Globulin Market Size Forecast by Region
12.1.1 Global Rabies Immune Globulin Forecast by Region (2024-2029)
12.1.2 Global Rabies Immune Globulin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rabies Immune Globulin Forecast by Type
12.7 Global Rabies Immune Globulin Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Rabies Immune Globulin Product Portfolios and Specifications
13.1.3 Merck Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Sanofi Pasteur
13.2.1 Sanofi Pasteur Company Information
13.2.2 Sanofi Pasteur Rabies Immune Globulin Product Portfolios and Specifications
13.2.3 Sanofi Pasteur Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Pasteur Main Business Overview
13.2.5 Sanofi Pasteur Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Rabies Immune Globulin Product Portfolios and Specifications
13.3.3 Novartis Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Beringer Ingelheim
13.4.1 Beringer Ingelheim Company Information
13.4.2 Beringer Ingelheim Rabies Immune Globulin Product Portfolios and Specifications
13.4.3 Beringer Ingelheim Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Beringer Ingelheim Main Business Overview
13.4.5 Beringer Ingelheim Latest Developments
13.5 Kedrion Biopharma
13.5.1 Kedrion Biopharma Company Information
13.5.2 Kedrion Biopharma Rabies Immune Globulin Product Portfolios and Specifications
13.5.3 Kedrion Biopharma Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Kedrion Biopharma Main Business Overview
13.5.5 Kedrion Biopharma Latest Developments
13.6 Shenzhen Kangtai Biological Products Co., Ltd.
13.6.1 Shenzhen Kangtai Biological Products Co., Ltd. Company Information
13.6.2 Shenzhen Kangtai Biological Products Co., Ltd. Rabies Immune Globulin Product Portfolios and Specifications
13.6.3 Shenzhen Kangtai Biological Products Co., Ltd. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Shenzhen Kangtai Biological Products Co., Ltd. Main Business Overview
13.6.5 Shenzhen Kangtai Biological Products Co., Ltd. Latest Developments
13.7 Chongqing Zhifei Biological Products Co., Ltd.
13.7.1 Chongqing Zhifei Biological Products Co., Ltd. Company Information
13.7.2 Chongqing Zhifei Biological Products Co., Ltd. Rabies Immune Globulin Product Portfolios and Specifications
13.7.3 Chongqing Zhifei Biological Products Co., Ltd. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Chongqing Zhifei Biological Products Co., Ltd. Main Business Overview
13.7.5 Chongqing Zhifei Biological Products Co., Ltd. Latest Developments
13.8 Liaoning Chengda Biotechnology Co., Ltd.
13.8.1 Liaoning Chengda Biotechnology Co., Ltd. Company Information
13.8.2 Liaoning Chengda Biotechnology Co., Ltd. Rabies Immune Globulin Product Portfolios and Specifications
13.8.3 Liaoning Chengda Biotechnology Co., Ltd. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Liaoning Chengda Biotechnology Co., Ltd. Main Business Overview
13.8.5 Liaoning Chengda Biotechnology Co., Ltd. Latest Developments
13.9 Hualan Biological Engineering,Inc.
13.9.1 Hualan Biological Engineering,Inc. Company Information
13.9.2 Hualan Biological Engineering,Inc. Rabies Immune Globulin Product Portfolios and Specifications
13.9.3 Hualan Biological Engineering,Inc. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hualan Biological Engineering,Inc. Main Business Overview
13.9.5 Hualan Biological Engineering,Inc. Latest Developments
13.10 China Resources Boya Bio-pharmaceutical Group Co., Ltd.
13.10.1 China Resources Boya Bio-pharmaceutical Group Co., Ltd. Company Information
13.10.2 China Resources Boya Bio-pharmaceutical Group Co., Ltd. Rabies Immune Globulin Product Portfolios and Specifications
13.10.3 China Resources Boya Bio-pharmaceutical Group Co., Ltd. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 China Resources Boya Bio-pharmaceutical Group Co., Ltd. Main Business Overview
13.10.5 China Resources Boya Bio-pharmaceutical Group Co., Ltd. Latest Developments
13.11 Shanxi Kangbao Biological Product Co., Ltd.
13.11.1 Shanxi Kangbao Biological Product Co., Ltd. Company Information
13.11.2 Shanxi Kangbao Biological Product Co., Ltd. Rabies Immune Globulin Product Portfolios and Specifications
13.11.3 Shanxi Kangbao Biological Product Co., Ltd. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanxi Kangbao Biological Product Co., Ltd. Main Business Overview
13.11.5 Shanxi Kangbao Biological Product Co., Ltd. Latest Developments
13.12 Wuhan Biopharmaceutical Co., Ltd. of China National Pharmaceutical Group
13.12.1 Wuhan Biopharmaceutical Co., Ltd. of China National Pharmaceutical Group Company Information
13.12.2 Wuhan Biopharmaceutical Co., Ltd. of China National Pharmaceutical Group Rabies Immune Globulin Product Portfolios and Specifications
13.12.3 Wuhan Biopharmaceutical Co., Ltd. of China National Pharmaceutical Group Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Wuhan Biopharmaceutical Co., Ltd. of China National Pharmaceutical Group Main Business Overview
13.12.5 Wuhan Biopharmaceutical Co., Ltd. of China National Pharmaceutical Group Latest Developments
13.13 Guangdong Wellen Pharmaceutical Co., Ltd.
13.13.1 Guangdong Wellen Pharmaceutical Co., Ltd. Company Information
13.13.2 Guangdong Wellen Pharmaceutical Co., Ltd. Rabies Immune Globulin Product Portfolios and Specifications
13.13.3 Guangdong Wellen Pharmaceutical Co., Ltd. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Guangdong Wellen Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Guangdong Wellen Pharmaceutical Co., Ltd. Latest Developments
13.14 Shenzhen Weiguang Biological Products Co., Ltd.
13.14.1 Shenzhen Weiguang Biological Products Co., Ltd. Company Information
13.14.2 Shenzhen Weiguang Biological Products Co., Ltd. Rabies Immune Globulin Product Portfolios and Specifications
13.14.3 Shenzhen Weiguang Biological Products Co., Ltd. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Shenzhen Weiguang Biological Products Co., Ltd. Main Business Overview
13.14.5 Shenzhen Weiguang Biological Products Co., Ltd. Latest Developments
13.15 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
13.15.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information
13.15.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Rabies Immune Globulin Product Portfolios and Specifications
13.15.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Main Business Overview
13.15.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Latest Developments
13.16 Guangdong Shuanglin Bio-Pharmacy Co., Ltd.
13.16.1 Guangdong Shuanglin Bio-Pharmacy Co., Ltd. Company Information
13.16.2 Guangdong Shuanglin Bio-Pharmacy Co., Ltd. Rabies Immune Globulin Product Portfolios and Specifications
13.16.3 Guangdong Shuanglin Bio-Pharmacy Co., Ltd. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Guangdong Shuanglin Bio-Pharmacy Co., Ltd. Main Business Overview
13.16.5 Guangdong Shuanglin Bio-Pharmacy Co., Ltd. Latest Developments
13.17 Wuhan Zhong Yuan Rui De Biological Products Co., Ltd.
13.17.1 Wuhan Zhong Yuan Rui De Biological Products Co., Ltd. Company Information
13.17.2 Wuhan Zhong Yuan Rui De Biological Products Co., Ltd. Rabies Immune Globulin Product Portfolios and Specifications
13.17.3 Wuhan Zhong Yuan Rui De Biological Products Co., Ltd. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Wuhan Zhong Yuan Rui De Biological Products Co., Ltd. Main Business Overview
13.17.5 Wuhan Zhong Yuan Rui De Biological Products Co., Ltd. Latest Developments
13.18 Shandong Taibang Biological Products Co., Ltd.
13.18.1 Shandong Taibang Biological Products Co., Ltd. Company Information
13.18.2 Shandong Taibang Biological Products Co., Ltd. Rabies Immune Globulin Product Portfolios and Specifications
13.18.3 Shandong Taibang Biological Products Co., Ltd. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Shandong Taibang Biological Products Co., Ltd. Main Business Overview
13.18.5 Shandong Taibang Biological Products Co., Ltd. Latest Developments
13.19 Bohui Biopharmaceutical (Hebei) Co., Ltd.
13.19.1 Bohui Biopharmaceutical (Hebei) Co., Ltd. Company Information
13.19.2 Bohui Biopharmaceutical (Hebei) Co., Ltd. Rabies Immune Globulin Product Portfolios and Specifications
13.19.3 Bohui Biopharmaceutical (Hebei) Co., Ltd. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Bohui Biopharmaceutical (Hebei) Co., Ltd. Main Business Overview
13.19.5 Bohui Biopharmaceutical (Hebei) Co., Ltd. Latest Developments
13.20 Tonrol Bio-Pharmaceutical Co.,Limited
13.20.1 Tonrol Bio-Pharmaceutical Co.,Limited Company Information
13.20.2 Tonrol Bio-Pharmaceutical Co.,Limited Rabies Immune Globulin Product Portfolios and Specifications
13.20.3 Tonrol Bio-Pharmaceutical Co.,Limited Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Tonrol Bio-Pharmaceutical Co.,Limited Main Business Overview
13.20.5 Tonrol Bio-Pharmaceutical Co.,Limited Latest Developments
13.21 Hunan Ziguang Huhan Nanyue Pharmaceutical Co., Ltd.
13.21.1 Hunan Ziguang Huhan Nanyue Pharmaceutical Co., Ltd. Company Information
13.21.2 Hunan Ziguang Huhan Nanyue Pharmaceutical Co., Ltd. Rabies Immune Globulin Product Portfolios and Specifications
13.21.3 Hunan Ziguang Huhan Nanyue Pharmaceutical Co., Ltd. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Hunan Ziguang Huhan Nanyue Pharmaceutical Co., Ltd. Main Business Overview
13.21.5 Hunan Ziguang Huhan Nanyue Pharmaceutical Co., Ltd. Latest Developments
13.22 Chengdu Rongsheng Pharmaceuticals Co., Ltd.
13.22.1 Chengdu Rongsheng Pharmaceuticals Co., Ltd. Company Information
13.22.2 Chengdu Rongsheng Pharmaceuticals Co., Ltd. Rabies Immune Globulin Product Portfolios and Specifications
13.22.3 Chengdu Rongsheng Pharmaceuticals Co., Ltd. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Chengdu Rongsheng Pharmaceuticals Co., Ltd. Main Business Overview
13.22.5 Chengdu Rongsheng Pharmaceuticals Co., Ltd. Latest Developments
13.23 Harbin Pacific Biopharmaceutical Co., Ltd.
13.23.1 Harbin Pacific Biopharmaceutical Co., Ltd. Company Information
13.23.2 Harbin Pacific Biopharmaceutical Co., Ltd. Rabies Immune Globulin Product Portfolios and Specifications
13.23.3 Harbin Pacific Biopharmaceutical Co., Ltd. Rabies Immune Globulin Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Harbin Pacific Biopharmaceutical Co., Ltd. Main Business Overview
13.23.5 Harbin Pacific Biopharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion